NL-OMON26235RecruitingNot Applicable
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity
Sint Maartenskliniek Research0 sites10 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •A minimum of 6 months post-lesion/post-stroke to ensure that the subject has a stable neurological condition, without clinical alterations.
- •- Age 18 years or older at the time of the study
- •- Spasticity of any/all of the m. triceps surae, i.e. have a MAS/Tardieu score = 1
- •- Have an ankle joint range of motion (ROM) of at least 20°in the sagittal plane
- •- Ability to make a transfer on to the Achilles (medical device)
- •- Current treatment of any/all of the m. triceps surae with BoNT-A for spasticity reduction
Exclusion Criteria
- •- Have a MAS score of 4
- •- Receive BoNT-A combined with other therapies aimed at reducing spasticity
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of botulinum toxin (BoNT-A) injections on intrinsic and reflexive contributions to ankle joint resistance for patients with spasticity.StrokeNL-OMON48057Stichting Sint Maartenskliniek10
Active, not recruiting
Not Applicable
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. - Botulinum toxin type A injections in stiff knee gaitStroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients.EUCTR2009-018226-29-NL26
Completed
Phase 3
The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with stiff knee gaitstiff knee gaitstiff-legged knee1000796310057166NL-OMON39359Revalidatiecentrum Het Roessingh26
Completed
Phase 2
botulinum toxin type A and diabetic neuropathyDiabeticr polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE10.42IRCT20190129042540N1Rafsanjan University of Medical Sciences50
Not yet recruiting
Not Applicable
The effect of botulinum toxin-A(BTX-A) injection for equinovarus deformity in children with unilateral cerebral palsy.Diseases of the nervous systemKCT0000530Yonsei University Health System, Severance Hospital30